Share
47,191 Posts.
lightbulb Created with Sketch. 2
clock Created with Sketch.
02/07/24
23:11
Share
Originally posted by Hingdog:
↑
Matey people dumped CHN because it's project metrics don't look like they stack up, even at the hopium level pricing used in the scoping study, short sellers were simply correct in their assessment. Those who got short near the highs did so because it was at an obscene valuation in an almighty bubble market, they would also know the vast majority of these projects never make it, there is no conspiracy ps there's some great stocks in this new bull, my account is up over 100% over the past year, some fantastic biotech stories helping people with cancer, brain diseases, etc etc. shame to be missing this cause you're stuck sooking about being proved wrong on some last bull market name
Expand
@Hingdog ; biotechs are about as speculative / high risk as it gets ... good luck! Although I agree with your comment that CHN rocketed beyond reality I'm one of those who took $Profits on its way up and who's now awaiting re-entry with little more than a toe in the water! Cheers and $Profitable investing!